These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3033309)

  • 21. Recombination occurs mainly between parental genomes and precedes DNA replication in pseudorabies virus-infected cells.
    Ben-Porat T; Brown L; Veach RA
    J Virol; 1982 Oct; 44(1):134-43. PubMed ID: 6292481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of pseudorabies virus glycoprotein gI in virus release from infected cells.
    Mettenleiter TC; Schreurs C; Zuckermann F; Ben-Porat T
    J Virol; 1987 Sep; 61(9):2764-9. PubMed ID: 3039168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of virulent pseudorabies (Aujeszky's disease) viral genome after single passage through nonswine animal species.
    Pirtle EC
    Can J Comp Med; 1984 Jul; 48(3):327-8. PubMed ID: 6089984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative rates of Aujeszky's disease virus attenuation, as assessed in mice.
    Chong YC; Förster U
    Vet Microbiol; 1987 Nov; 15(3):249-56. PubMed ID: 2829412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A high-temperature passaging attenuated Pseudorabies vaccine protects piglets completely against emerging PRV variant.
    Liang C; Tong W; Zheng H; Liu F; Wu J; Li G; Zhou EM; Tong G
    Res Vet Sci; 2017 Jun; 112():109-115. PubMed ID: 28214681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenicity and genomic characterization of a pseudorabies virus variant isolated from Bartha-K61-vaccinated swine population in China.
    Luo Y; Li N; Cong X; Wang CH; Du M; Li L; Zhao B; Yuan J; Liu DD; Li S; Li Y; Sun Y; Qiu HJ
    Vet Microbiol; 2014 Nov; 174(1-2):107-15. PubMed ID: 25293398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.
    Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R
    Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localization of the regions of homology between the genomes of herpes simplex virus, type 1, and pseudorabies virus.
    Ben-Porat T; Veach RA; Ihara S
    Virology; 1983 May; 127(1):194-204. PubMed ID: 6305015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The a sequence is dispensable for isomerization of the herpes simplex virus type 1 genome.
    Martin DW; Weber PC
    J Virol; 1996 Dec; 70(12):8801-12. PubMed ID: 8971009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth characteristics and complete genomic sequence analysis of a novel pseudorabies virus in China.
    Yu T; Chen F; Ku X; Fan J; Zhu Y; Ma H; Li S; Wu B; He Q
    Virus Genes; 2016 Aug; 52(4):474-83. PubMed ID: 27012685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations affecting the UL21 gene contribute to avirulence of pseudorabies virus vaccine strain Bartha.
    Klupp BG; Lomniczi B; Visser N; Fuchs W; Mettenleiter TC
    Virology; 1995 Oct; 212(2):466-73. PubMed ID: 7571416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presence of markers for virulence in the unique short region or repeat region or both of pseudorabies hybrid viruses.
    Berns A; van den Ouweland A; Quint W; van Oirschot J; Gielkens A
    J Virol; 1985 Jan; 53(1):89-93. PubMed ID: 2981366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the safety and efficacy of a thymidine kinase, inverted repeat, gI, and gpX gene-deleted pseudorabies vaccine.
    Swenson SL; McMillen J; Hill HT
    J Vet Diagn Invest; 1993 Jul; 5(3):341-6. PubMed ID: 8396983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complex between glycoproteins gI and gp63 of pseudorabies virus: its effect on virus replication.
    Zuckermann FA; Mettenleiter TC; Schreurs C; Sugg N; Ben-Porat T
    J Virol; 1988 Dec; 62(12):4622-6. PubMed ID: 2460638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability of the pseudorabies virus genome after in vivo serial passage.
    Wathen MW; Pirtle EC
    J Gen Virol; 1984 Aug; 65 ( Pt 8)():1401-4. PubMed ID: 6086823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic compatibility of a thymidine kinase, inverted repeat, gI, and gpX modified live gene-deleted PRV vaccine with three differential ELISAs.
    Swenson SL; McMillen J; Hill HT
    J Vet Diagn Invest; 1993 Jul; 5(3):347-50. PubMed ID: 8396984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombination of pseudorabies virus vaccine strains in swine.
    Henderson LM; Levings RL; Davis AJ; Sturtz DR
    Am J Vet Res; 1991 Jun; 52(6):820-5. PubMed ID: 1652903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pseudorabies virus recombinant simultaneously lacking the major tegument proteins encoded by the UL46, UL47, UL48, and UL49 genes is viable in cultured cells.
    Fuchs W; Granzow H; Mettenleiter TC
    J Virol; 2003 Dec; 77(23):12891-900. PubMed ID: 14610211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycoprotein gIII of pseudorabies virus is multifunctional.
    Schreurs C; Mettenleiter TC; Zuckermann F; Sugg N; Ben-Porat T
    J Virol; 1988 Jul; 62(7):2251-7. PubMed ID: 2836609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The capsid-associated UL25 protein of the alphaherpesvirus pseudorabies virus is nonessential for cleavage and encapsidation of genomic DNA but is required for nuclear egress of capsids.
    Klupp BG; Granzow H; Keil GM; Mettenleiter TC
    J Virol; 2006 Jul; 80(13):6235-46. PubMed ID: 16775311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.